Clinical trial
MAPS Trial: Matrix And Platinum Science
NCT00396981 · Stryker Neurovascular, Industry · Completed
Key facts
| NCT number | NCT00396981 |
|---|---|
| Title | MAPS Trial: Matrix And Platinum Science |
| Official title | A Prospective, Randomized, Multicenter Trial Investigating Matrix 2® and GDC® Detachable Coils for the Treatment of Intracranial Saccular Aneurysms |
| Acronym | MAPS |
| Lead sponsor | Stryker Neurovascular, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Intracranial Aneurysms |
| Intervention type | Device |
| Interventions | Matrix 2® coils for endovascular aneurysm occlusion, GDC® coils for endovascular aneurysm occlusion |
| Enrollment | 626 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Mar 1, 2015 |
| First posted | Nov 8, 2006 |
| Last update posted | Feb 17, 2016 |
| Countries | Australia, Canada, China, France, Germany, Mexico, Norway, Spain, Turkey (Türkiye), United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: